Drug reference
lumiracoxib
COX-2 inhibitor (coxib) · Anti-inflammatory, Analgesic
COX-2 inhibitor (coxib)Anti-inflammatory, Analgesic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Selectively inhibits cyclooxygenase-2 (COX-2).
Contraindications
- Restricted in use or withdrawn from market due to cardiovascular risk profile
Side effects
Serious
- Hepatotoxicity
- Cardiovascular risk
Related guidelines
Other COX-2 inhibitor (coxib) drugs
Ask House about lumiracoxib
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team